Daily News Podcast

A hidden bonus for rivaroxaban?

Publish date: September 24, 2018

 

Bleeding from rivaroxaban may help diagnose some GI and GU cancers. Also today, a review by the FDA supports the safety of nuplazid, arthritis is prevalent in older adults with any degree of depression, and growth in overdose deaths is exponential.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Modest alcohol and NAFLD
MDedge Rheumatology
Cardiovascular risk with diclofenac
MDedge Rheumatology
Baloxavir, oseltamivir similar for influenza
MDedge Rheumatology
New guidelines on prophylaxis for cancer-related immunosuppresion
MDedge Rheumatology
Urine drug screens show improper medication use
MDedge Rheumatology
Alarming rate of diabetes medication discontinuations
MDedge Rheumatology
Troubling MRI changes and pediatric hypertension
MDedge Rheumatology
New insight into celiac disease: What you should know
MDedge Rheumatology
Behavioral intervention in obese adults
MDedge Rheumatology
What you should know about celiac disease
MDedge Rheumatology